SE8305467L - 1,4-dihydropyridinderivat - Google Patents

1,4-dihydropyridinderivat

Info

Publication number
SE8305467L
SE8305467L SE8305467A SE8305467A SE8305467L SE 8305467 L SE8305467 L SE 8305467L SE 8305467 A SE8305467 A SE 8305467A SE 8305467 A SE8305467 A SE 8305467A SE 8305467 L SE8305467 L SE 8305467L
Authority
SE
Sweden
Prior art keywords
carbon atoms
nitratoalkyl
compounds
artery disease
dihydropyridine
Prior art date
Application number
SE8305467A
Other languages
English (en)
Other versions
SE8305467D0 (sv
SE440648B (sv
Inventor
K Hatayama
A Nakazato
T Ogawa
S Ito
J Sawada
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of SE8305467D0 publication Critical patent/SE8305467D0/sv
Publication of SE8305467L publication Critical patent/SE8305467L/sv
Publication of SE440648B publication Critical patent/SE440648B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8305467A 1982-04-22 1983-10-05 1,4-dihydropyridin-dikarboxylsyra-nitratoalkylestrar SE440648B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57067759A JPS58185562A (ja) 1982-04-22 1982-04-22 1,4−ジヒドロピリジン誘導体

Publications (3)

Publication Number Publication Date
SE8305467D0 SE8305467D0 (sv) 1983-10-05
SE8305467L true SE8305467L (sv) 1985-04-06
SE440648B SE440648B (sv) 1985-08-12

Family

ID=13354183

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305467A SE440648B (sv) 1982-04-22 1983-10-05 1,4-dihydropyridin-dikarboxylsyra-nitratoalkylestrar

Country Status (8)

Country Link
US (1) US4472411A (sv)
EP (1) EP0092936B1 (sv)
JP (1) JPS58185562A (sv)
AU (1) AU565424B2 (sv)
BE (1) BE898024A (sv)
DE (1) DE3370620D1 (sv)
NL (1) NL8303616A (sv)
SE (1) SE440648B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
GB8314744D0 (en) * 1983-05-27 1983-07-06 Fujisawa Pharmaceutical Co 2 6-disubstituted-1 4-dihydropyridine derivative
EP0127150A3 (en) * 1983-05-27 1987-07-22 Fujisawa Pharmaceutical Co., Ltd. 2,6-disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
US4730052A (en) * 1984-07-13 1988-03-08 Taisho Pharmaceutical Co., Ltd. Method for preparing unsymmetrical 1,4-dihydropyridine-3,5-dicarboxylic acid diesters
ES8708211A1 (es) 1985-06-14 1987-10-01 Sankyo Co Un procedimiento para la preparacion de nuevos derivados de 4-(fenil sustituido)-1,4-dihidropiridina.
JPS62174050A (ja) * 1985-10-21 1987-07-30 Nippon Shoji Kk 3−アミノカルボニル−1,4−ジヒドロピリジン−5−カルボン酸誘導体、その製法および医薬組成物
US4780538A (en) * 1986-02-12 1988-10-25 Merck & Co., Inc. Process for 1,4-dihydropyridine compounds using a titanamine catalyst
JPS62292757A (ja) * 1986-06-12 1987-12-19 Taisho Pharmaceut Co Ltd 1,4−ジヒドロピリジン誘導体
JPS6396126A (ja) * 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物
US5047543A (en) * 1988-11-24 1991-09-10 Taisho Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
NL9001752A (nl) * 1990-08-02 1992-03-02 Cedona Pharm Bv Nieuwe 1,4-dihydropyridinederivaten.
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
DE3370620D1 (en) 1987-05-07
EP0092936B1 (en) 1987-04-01
US4472411A (en) 1984-09-18
NL8303616A (nl) 1985-05-17
JPS58185562A (ja) 1983-10-29
AU1994183A (en) 1985-04-18
SE8305467D0 (sv) 1983-10-05
SE440648B (sv) 1985-08-12
BE898024A (fr) 1984-04-19
AU565424B2 (en) 1987-09-17
JPS635024B2 (sv) 1988-02-01
EP0092936A1 (en) 1983-11-02

Similar Documents

Publication Publication Date Title
SE8305467L (sv) 1,4-dihydropyridinderivat
IL116122A0 (en) Intermediates to heterocyclic-cyclic amine derivatives
LU91223I2 (fr) Ivabradine et ses dérivés pharmaceutiquement acceptables (procoralan)
FR2383171A1 (fr) Derives de thiopropanoylaminoacides utiles comme hypotenseurs
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
ES515081A0 (es) "procedimiento para la preparacion de derivados de 6-metilprednisolona".
FI822203L (fi) Nya 2-aryl-3,4-diaza-bicyklo/4,n,0/-alken-(2)-oner-(5), foerfarande foer deras framstaellning och dessa innehaollande laekemedel
FR2384745A1 (fr) Derives de la somatostatine et leur preparation
FR2389594A1 (sv)
FI891986A (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
FI830397L (fi) Foerfarande foer framstaellning av imidazolidinderivat
FR2428045A1 (fr) Derives silyles de naphtacenones utilisables notamment dans la synthese d'agents antitumeurs
FR2387215A1 (fr) 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives
FR2389597A1 (sv)
DE3460834D1 (en) Derivatives of bicyclo(4.2.0)octatriene-1,3,5, their preparation and their therapeutical application
LV10234A (lv) Trijodbenzola savienojumu iegusanas metode
FR2389615A1 (sv)
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
NO811185L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tiazolderivater.
ES501744A0 (es) Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas
FR2429202A1 (sv)
DK416289A (da) Estere af 3-demethylthiocolchicin og n-acylanaloger
FR2381008A1 (fr) Nouveaux patchoulols hydroxyles
FR2420524A1 (fr) Benzo-cyclitolamines et leurs utilisations therapeutiques comme agents hypotenseurs
ES2002325A6 (es) Un procedimiento para preparar un derivado de dihidropiridina

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8305467-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8305467-6

Format of ref document f/p: F